Trials / Conditions / New-onset Type 1 Diabetes Mellitus
New-onset Type 1 Diabetes Mellitus
4 registered clinical trials studyying New-onset Type 1 Diabetes Mellitus.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Tocilizumab (TCZ) in New-onset Type 1 Diabetes NCT02293837 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Terminated | Inducing Remission in Type 1 Diabetes With Alefacept NCT00965458 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Terminated | Study of Antithymocyte Globulin for Treatment of New-onset T1DM NCT00515099 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Withdrawn | A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects W NCT00214214 | University of Wisconsin, Madison | Phase 1 |